课题基金 / 基金详情

NUCLEOSIDE TRANSPORTERS

NUCLEOSIDE TRANSPORTERS
核苷转运蛋白
批准号:
7719126
负责人:
CHOUKRI BEN MAMOUN
金额:
$0.29万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2009-03-31

项目摘要

项目成果

CHOUKRI BEN MAMOUN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Malaria, a disease caused by protozaon parasites of the genus Plasmodium, is one of the most dangerous infectious disease affecting human populations. The purpose of this research is to determine the conditions that help the multiplication of the parasite in human red blood cells. The scientific information received from this study may help understand the disease and identify new drugs or a vaccine against malaria. Research in the Lab will focus on how the Human Malaria Parasite develops within human red blood cells. Our goal is to characterize, at the molecular level, the pathways essential for the parasite survival with an eye toward future drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fosinopril analogs for the treatment of human babesiosis
  • 批准号:
    10396069
  • 项目类别:
  • 资助金额:
    $72.59万
  • 财政年份:
    2021
  • 负责人:
    CHOUKRI BEN MAMOUN
  • 依托单位:
Fosinopril analogs for the treatment of human babesiosis
  • 批准号:
    10211812
  • 项目类别:
  • 资助金额:
    $74.28万
  • 财政年份:
    2021
  • 负责人:
    CHOUKRI BEN MAMOUN
  • 依托单位:
Fosinopril analogs for the treatment of human babesiosis
  • 批准号:
    10594970
  • 项目类别:
  • 资助金额:
    $72.59万
  • 财政年份:
    2021
  • 负责人:
    CHOUKRI BEN MAMOUN
  • 依托单位:
Antigen Discovery and Vaccine Development for Human Babesia Parasites
  • 批准号:
    10386919
  • 项目类别:
  • 资助金额:
    $41.88万
  • 财政年份:
    2020
  • 负责人:
    CHOUKRI BEN MAMOUN
  • 依托单位:
海外基金